Abstract | OBJECTIVE: ANIMALS: 24 Standardbred horses. PROCEDURE: Aseptic arthritis was induced in the right intercarpal joint by i.a. injection of amphotericin B (20 mg). One week later (day 0), horses were randomly assigned to four 6-horse treatment groups and treated with i.a. injection of 10, 20, or 40 mg of bufexamac suspension (20 mg/ml) or 2.0 ml of sterile saline (0.9% NaCl) solution (control). The treatment was repeated once after 7 days. Clinical lameness examinations and synovial fluid (SF) analyses were done prior to induction and at weekly intervals for 5 weeks (days 0, 7, 14, 21 and 28). RESULTS: CONCLUSIONS AND CLINICAL RELEVANCE: 2 i.a. injections of 20 or 40 mg of bufexamac, at weekly intervals, were effective in reducing clinical signs of lameness and SF activity of BGLUC associated with amphotericin B-induced carpal joint arthritis. Bufexamac possesses anti-inflammatory properties useful for i.a. treatment of lameness associated with aseptic arthritis in horses.
|
Authors | M M Suominen, R M Tulamo, L M Puupponen, S M Sankari |
Journal | American journal of veterinary research
(Am J Vet Res)
Vol. 60
Issue 12
Pg. 1467-73
(Dec 1999)
ISSN: 0002-9645 [Print] United States |
PMID | 10622153
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Bufexamac
- Amphotericin B
|
Topics |
- Amphotericin B
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
(administration & dosage, therapeutic use)
- Arthritis
(chemically induced, veterinary)
- Bufexamac
(administration & dosage, therapeutic use)
- Horse Diseases
(chemically induced, drug therapy)
- Horses
- Injections, Intra-Articular
- Lameness, Animal
(drug therapy)
- Synovial Fluid
(chemistry)
|